115 related articles for article (PubMed ID: 32955957)
1. Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.
Calza L; Colangeli V; Borderi M; Beci G; Esposito F; Bon I; Re MC; Viale P
Infect Dis (Lond); 2021 Feb; 53(2):81-88. PubMed ID: 32955957
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
Longenecker CT; Sattar A; Gilkeson R; McComsey GA
AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
[TBL] [Abstract][Full Text] [Related]
3. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
[TBL] [Abstract][Full Text] [Related]
4. Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy.
Calza L; Colangeli V; Magistrelli E; Contadini I; Bon I; Re MC; Conti M; Mancini R; Viale P
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):126-132. PubMed ID: 27618139
[TBL] [Abstract][Full Text] [Related]
5. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients.
Calza L; Vanino E; Salvadori C; Manfredi R; Colangeli V; Cascavilla A; Di Bari MA; Motta R; Viale P
HIV Clin Trials; 2014; 15(1):1-13. PubMed ID: 24518210
[TBL] [Abstract][Full Text] [Related]
7. Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.
Hileman CO; McComsey GA
AIDS Res Hum Retroviruses; 2018 Mar; 34(3):282-285. PubMed ID: 28974102
[TBL] [Abstract][Full Text] [Related]
8. Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study.
Yokoi H; Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yamazaki T; Yoshida M
Int Heart J; 2014; 55(2):146-52. PubMed ID: 24632963
[TBL] [Abstract][Full Text] [Related]
9. Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis.
Liu Z; Zhao Y; Wei F; Ye L; Lu F; Zhang H; Diao Y; Song H; Qi Z
Atherosclerosis; 2014 Mar; 233(1):291-9. PubMed ID: 24495792
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors.
Calza L; Trapani F; Bartoletti M; Manfredi R; Colangeli V; Borderi M; Grossi G; Motta R; Viale P
HIV Clin Trials; 2012; 13(3):153-61. PubMed ID: 22592095
[TBL] [Abstract][Full Text] [Related]
11. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA
Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434
[TBL] [Abstract][Full Text] [Related]
12. Effect of statin on arginine metabolites in treated HIV-infection.
Dirajlal-Fargo S; El Kamari V; Sattar A; Alam K; Funderburg N; Labbato D; Pirro L; Longenecker CT; Wilson WH; McComsey GA
Atherosclerosis; 2017 Nov; 266():74-80. PubMed ID: 28992467
[TBL] [Abstract][Full Text] [Related]
13. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
Crouse JR; Grobbee DE; O'Leary DH; Bots ML; Evans GW; Palmer MK; Riley WA; Raichlen JS;
Cardiovasc Drugs Ther; 2004 May; 18(3):231-8. PubMed ID: 15229392
[TBL] [Abstract][Full Text] [Related]
14. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
15. Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome.
Al-Shorman A; Al-Domi H; Faqih A
Swiss Med Wkly; 2017; 147():w14446. PubMed ID: 28634974
[TBL] [Abstract][Full Text] [Related]
16. Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis-design, rationale, and methodology of the METEOR-China study.
Wang Y; Wang A; Li H; Li Z; Hu B; Li X; Zheng H; Fu L; Hu H; Nie Z; Qin Y; Zhao B; Wei D; Karlson BW; Bots ML; Chen Y; Wang Y
Trials; 2020 Nov; 21(1):921. PubMed ID: 33176842
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.
Kawamoto R; Tomita H; Ohtsuka N; Inoue A; Kamitani A
J Atheroscler Thromb; 2007 Apr; 14(2):78-85. PubMed ID: 17485892
[TBL] [Abstract][Full Text] [Related]
18. The association between ghrelin levels and markers of arterial stiffness and inflammatory markers in Saudi subjects with metabolic syndrome.
Ali TM; Mehanna OM; El Askary A
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S721-S725. PubMed ID: 28539201
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Carotid Intima-Media Thickness with some Inflammatory Biomarkers, Ghrelin and Adiponectin in Iranians with and without Metabolic Syndrome in Isfahan Cohort Study.
Hajmohammadi T; Sadeghi M; Dashti M; Hashemi M; Saadatnia M; Soghrati M; Talaei M; Sarrafzadegan N
ARYA Atheroscler; 2010; 6(2):56-61. PubMed ID: 22577415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
